Connect with us

Healthcare

South Dakota To Be First State To Conduct Hydroxychloroquine Trials

Published

on

South Dakota Governor Kristi Noem announced Monday that her state will be the first to conduct clinical trials of hydroxychloroquine, a drug hailed by many doctors and patients as a miracle solution in the fight against an invisible enemy, the coronavirus.

“From day one, I’ve said we’re going to let the science, facts, and data drive our decision-making in South Dakota. Throughout last week, I communicated with White House officials to let them know that South Dakota’s medical community was ready to step up and lead the way on research efforts,” Noem said in Monday’s press release.

https://twitter.com/realDonaldTrump/status/1241367245143642113

Her statement continued, “I made direct requests to President Trump and Vice President Pence to supply us with enough hydroxychloroquine so that it could be made available for every hospitalized person the state may have as well as for those healthcare workers on the frontlines and those in the most vulnerable populations.”

The U.S. Food and Drug Administration authorized the emergency use of hydroxychloroquine last month after it showed promising results of recovery in early clinical trials. The anti-malaria pill, coupled with the antibiotic azithromycin, has since been used to treat many patients diagnosed with the coronavirus.

South Dakota will soon test the drug on a larger scale with the help of Sanford Health, Avera and Monument Health. The three providers will treat up to 100,000 coronavirus patients, healthcare workers and anyone else with high-risk of exposure to the virus, according to the press release.

The state currently has 868 confirmed cases of the virus and has seen six deaths.

You may like

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Healthcare

American and Southwest stand by vaccine mandate, despite Abbott’s ban

Published

on

Southwest shutterstock 606188015

American Airlines and Southwest Airlines are still planning to comply with President Biden’s executive order regarding the COVID-19 vaccine. The order requires all their employees to be vaccinated by Dec. 8t. As a result, they will be ignoring Texas Governor Greg Abbott’s ban on vaccine mandates.

Abbott announced his own executive order, effectively banning mandates even from private employers, on Tuesday. “In another instance of federal overreach, the Biden Administration is now bullying many private entities into imposing COVID-19 vaccine mandates, causing workforce disruptions that threaten Texas’ continued recovery from the COVID-19 disaster,” Abbott said. “The COVID-19 vaccine is safe, effective, and our best defense against the virus, but should remain voluntary and never forced.”

Yet both airlines are requiring their employees to be vaccinated by Nov. 24. This comes despite Southwest’s impromptu cancellation of over 2,000 flights over the weekend. At the time, the airline blamed the cancellations on air traffic control and weather conditions. However, SaraACarter.com was unable to verify that any other airline had to cancel near as many flights for the same reasons. This has left many to speculate that Southwest actually cancelled flights due to their employees walking out as a direct result of the mandate.

Reporter Jack Posobiec tweeted out a flyer circulating among the anti-vaxx Southwest employees. Currently, they are planning a protest outside of Southwest headquarters next Monday. The protest will be called “Freedom Not Force.”

Southwest told Reuters it “would be expected to comply with the President’s Order to remain compliant as a federal contractor.” In addition, American similarly said Abbott’s order does not change anything.

You can follow Jenny Goldsberry on Twitter @jennyjournalism.

You may like

Continue Reading
Advertisement

Trending Now

Advertisement

Trending

Subscribe To Sara's Newsletter

Subscribe To Sara's Newsletter

Join Sara's mailing list to receive the latest stories as soon as they're available!

You have Successfully Subscribed!